ウェアラブルインジェクターの世界市場規模：タイプ別、療法別、エンドユーザー別、地域別、範囲および予測

ウェアラブルインジェクターの市場規模と予測

ウェアラブルインジェクター市場規模は、2023年に86億2,000万米ドルと評価され、2031年には187億7,000万米ドルに達すると予測され、2024年から2031年までのCAGRは10.21%で成長します。ウェアラブルインジェクターは、従来のハンドヘルド携帯機器を使って薬剤を投与するために使用されます。これは、患者が定期的に薬を服用するために使用する、自己拡張可能な自己投与システムです。糖尿病、肥満、高血圧などの慢性疾患を患っている人々にとって不可欠なものです。ウェアラブルインジェクターは、注意深い監視のもと、医療用液剤の正確な送達を改善します。病院、在宅介護施設、診療所などで広く使用されています。糖尿病、心血管疾患、がんなどの慢性疾患の有病率が上昇していることに加え、疾患治療のためにモノクローナル抗体などの生物製剤の使用が増加していること、スマートフォンとのBluetooth接続やデジタルディスプレイなどの機能を備えたウェアラブルインジェクターの研究開発活動が活発化していることから、市場は拡大しています。

老年患者の増加と在宅治療の需要が市場を前進させています。さらに、確立されたヘルスケア・インフラの存在、生活習慣病の頻度増加も市場拡大の2つの要因です。しかし、ウェアラブルインジェクター市場は、新興国市場における需要の低さと、ウェアラブルインジェクターに関連するコストの高さによって抑制されると予測されます。

ウェアラブルインジェクターは、ヘルスケア・インフラやコネクテッド・ヘルス・サービスにおける大きなギャップを解決すると期待されています。慢性の肺疾患、心血管疾患、神経疾患の患者がその長期的な影響を管理し始めるにつれて、COVID-19の罹患による慢性疾患の増加がウェアラブルインジェクターの採用における開発の推進力となる可能性があります。慢性疾患の患者は、COVID-19への曝露を避けるため、診療所から自宅での薬剤投与への切り替えを求めています。

ウェアラブルインジェクターの世界市場力学

ウェアラブルインジェクターの世界市場を形成している主な市場力学

主な市場促進要因

慢性疾患の有病率の上昇

糖尿病、がん、自己免疫疾患などの慢性疾患の有病率の上昇により、頻繁かつ正確な薬物送達が必要となり、その結果、シンプルで効果的な治療の選択肢を提供するウェアラブルインジェクターデバイスが望まれています。

技術の進歩

素材の改良、小型化、ワイヤレス通信など、ウェアラブル技術における技術の進歩は、ウェアラブルインジェクターの機能性と使いやすさを向上させ、患者やヘルスケア専門家にとってより魅力的なものとなっています。

在宅ケアに対する患者の嗜好：

通院回数とヘルスケアコストを削減したいという願望に後押しされ、薬剤の自己投与と在宅ケアの傾向が高まっています。ウェアラブルインジェクターは、患者が独立して治療を管理するための効率的なソリューションを提供します。

支持的な規制政策：

FDAやEMAのような保健当局による有利な規制枠組みやウェアラブルインジェクターの承認の増加は、市場の成長を促進します。これらの政策はウェアラブルインジェクターの安全性、有効性、品質を保証し、臨床現場での採用を後押ししています。

主な課題

規制上のハードルとコンプライアンス：

複雑で厳しい規制状況を乗り切ることは、ウェアラブルインジェクターにとって大きなハードルです。製造業者は、製品がFDAやEMAを含む複数の世界の保健機関の規制基準を満たしていることを保証しなければならないです。これには、安全性と有効性を証明するための広範な試験と文書化が必要となり、時間と費用がかかります。コンプライアンス違反は、製品承認や市場参入の遅れの原因となり、収益や市場競争に影響を与えます。

技術的・設計的課題：

使い勝手がよく、信頼性が高く、さまざまな薬剤を正確に送達できるウェアラブルインジェクターを作るには、技術的に大きな障害があります。小型、軽量で快適なガジェットを維持しながら、接続や自動ドラッグデリバリーなどの高度な機能を組み合わせるには、専門的なエンジニアリングが必要です。さまざまな気象条件や使用シナリオのもとで機器の性能を維持することは、さらに問題を複雑にしています。

市場の受容と採用：

医療従事者や患者から受け入れられ、採用されることは非常に重要だが、難しいです。新しい技術への不慣れや、安全性や有効性への懸念が、しばしば抵抗の原因となります。これらの障壁を克服するには、利害関係者を教育し、利点を示し、機器が既存のヘルスケア診療に容易に統合できるようにする必要があります。患者のアドヒアランスも重要であるため、直感的で邪魔にならないデザインでなければなりません。

コストと償還の問題：

ウェアラブルインジェクターは開発・製造コストが高く、価格設定や市場浸透に課題があります。保険会社から償還を受けることは、より広く普及するために重要であるが、費用対効果や臨床上の優位性を示す強力な証拠がなければ難しいです。メーカーは保険支払者と協力して有利な償還ルートを構築しなければならないが、これには費用のかかる臨床研究や医療経済調査が含まれることがあります。

主要動向：

技術の進歩と革新：

ウェアラブルインジェクターへのスマート機能の搭載などの技術進歩により、市場は急速に拡大しています。これらの機能には、Bluetooth接続、リアルタイムモニタリング、アプリ統合などがあり、患者のコンプライアンスを向上させ、ヘルスケアプロバイダーに有用なデータを提供します。

慢性疾患の有病率の増加：

糖尿病、がん、自己免疫疾患などの慢性疾患の有病率の増加は、ウェアラブルインジェクターの需要を煽っています。これらの機器は、長期的な処方レジメンを管理するための実用的かつ効果的なアプローチを提供し、自宅でのケアを可能にすることで患者のQOLを高める。

患者中心のヘルスケアソリューション：

患者中心のヘルスケアが重視されるようになり、ウェアラブルインジェクターのイントロダクションが推進されています。これらの器具は使いやすく設計されており、不快感を軽減し、自己注射を可能にしています。このような動きは、人々が自らのケアを管理できるようにすることで、個別化医療の動向を促進します。

規制当局の承認と市場の拡大：

ウェアラブルインジェクターが世界中で規制当局の認可を取得するにつれて、市場は開拓されつつあります。これにより、入手可能性が拡大するだけでなく、安全性と有効性に対する顧客の信頼も高まっています。さらに、企業は戦略的提携や協業を通じて市場での存在感を高めており、これにより製品へのリーチと採用率が向上しています。

目次

第1章 ウェアラブルインジェクターの世界市場：イントロダクション

• 市場のイントロダクション
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 ウェアラブルインジェクターの世界市場展望

• 概要
• 市場力学
• 促進要因
• 抑制要因
• 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 ウェアラブルインジェクターの世界市場：タイプ別

• 概要
• オンボディインジェクター
• オフボディインジェクター

第6章 ウェアラブルインジェクターの世界市場：療法別

• 概要
• 免疫腫瘍学
• 糖尿病
• 心血管疾患

第7章 ウェアラブルインジェクターの世界市場：エンドユーザー別

• 概要
• 病院
• 在宅医療
• 診療所

第8章 ウェアラブルインジェクターの世界市場：地域別

• 概要
• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• ドイツ
• 英国
• フランス
• その他欧州
• アジア太平洋
• 中国
• 日本
• インド
• その他アジア太平洋地域
• 世界のその他の地域
• ラテンアメリカ
• 中東・アフリカ

第9章 ウェアラブルインジェクターの世界市場：競合情勢

• 概要
• 各社の市場ランキング
• 主な開発戦略

第10章 企業プロファイル

• Valeritas
• SteadyMed Therapeutics
• Tandem Diabetes Care
• Amgen
• Medtronic
• Insulet Corporation
• United Therapeutic Corporation
• Enable Injections
• Ypsomed and Becton
• Dickinson and Company

第11章 付録

• 関連調査

Wearable Injector Devices Market Size And Forecast

Wearable Injector Devices Market size was valued at USD 8.62 Billion in 2023 and is projected to reach USD 18.77 Billion by 2031 , growing at a CAGR of 10.21% from 2024 to 2031. Wearable injectors are used to give drugs through a conventional handheld portable device. It is a self-scalable, self-administration system that patients use to take their medication on a regular basis. It is essential for people suffering from chronic conditions like diabetes, obesity, and hypertension. The wearable injector improves the accurate delivery of medical fluid under careful supervision. It is widely used in hospitals, home care facilities, clinics, and other settings. The market is growing due to the rising prevalence of chronic diseases such as diabetes, cardiovascular disease, and cancer, as well as the increased use of biologics such as monoclonal antibodies for disease treatment and increased R&D activities in wearable injector devices with features such as Bluetooth connectivity with a smartphone and a digital display.

The growing number of geriatric patients and demand for home-based therapy are moving the market ahead. Furthermore, the presence of well-established healthcare infrastructure, as well as an increase in the frequency of lifestyle-related disorders, are two other factors driving market expansion. However, the Wearable Injector Devices Market is projected to be restrained by low demand in developing nations and the high costs associated with wearable injectors.

Wearable injectors are expected to solve significant gaps in healthcare infrastructure and connected health services. As patients with chronic pulmonary, cardiovascular, and neurological problems begin to manage the long-term consequences of the condition, an increase in chronic ailments caused by COVID-19 morbidity may help drive development in the adoption of wearable injectors. Patients with chronic conditions are asking a switch from clinic to at-home drug administration to avoid COVID-19 exposure.

Global Wearable Injector Devices Market Dynamics

The key market dynamics that are shaping the global Wearable Injector Devices Market include:

Key Market Drivers:

Rising Prevalence of Chronic Diseases

: The rising prevalence of chronic diseases such as diabetes, cancer, and autoimmune disorders needs frequent and precise drug delivery, resulting in a desire for wearable injector devices that provide simple and effective treatment choices.

Technological Advancements

: Technological advancements in wearable technology, including as improved materials, downsizing, and wireless communication, improve the functionality and usability of wearable injectors, making them more appealing to patients and healthcare professionals.

Patient Preference for Home-Based Care:

There is a growing trend towards self-administration of medications and home-based care, fueled by the desire to reduce hospital visits and healthcare costs. Wearable injectors provide an efficient solution for patients to manage their treatment independently.

Supportive Regulatory Policies:

Favorable regulatory frameworks and increased approvals of wearable injector devices by health authorities like the FDA and EMA facilitate market growth. These policies ensure the safety, efficacy, and quality of wearable injectors, boosting their adoption in clinical practice.

Key Challenges:

Regulatory Hurdles and Compliance:

Navigating the complicated and strict regulatory landscape is a significant hurdle for wearable injector devices. Manufacturers must guarantee that their products meet the regulatory standards of several worldwide health bodies, including the FDA and EMA. This entails extensive testing and documentation to prove safety and efficacy, which can be time-consuming and expensive. Non-compliance can cause delays in product approval and market access, affecting revenue and competitiveness.

Technological and Design Challenges:

Creating wearable injector devices that are user-friendly, dependable, and capable of precisely delivering a wide range of drugs has substantial technical obstacles. Keeping the gadgets small, lightweight, and comfy while combining advanced capabilities like connection and automated drug delivery necessitates expert engineering. Maintaining device performance under a variety of weather settings and usage scenarios further complicates matters.

Market Acceptance and Adoption:

Gaining acceptance and adoption from healthcare professionals and patients is crucial but difficult. Unfamiliarity with new technologies, as well as concerns about safety and efficacy, frequently cause resistance. Overcoming these barriers requires educating stakeholders, demonstrating advantages, and ensuring that the devices integrate easily into existing healthcare practices. Patient adherence is also critical, thus designs must be intuitive and least obtrusive.

Cost and Reimbursement Issues:

Wearable injector devices can be costly to develop and manufacture, offering pricing and market penetration challenges. Receiving reimbursement from insurance companies is critical for wider adoption, but this can be difficult without strong evidence of cost-effectiveness and clinical advantages. Manufacturers must collaborate with payers to build advantageous reimbursement routes, which can include costly clinical studies and health economic studies.

Key Trends:

Technological Advances and Innovations:

The market is expanding rapidly as a result of technological advances such as the incorporation of smart features into wearable injectors. These features include Bluetooth connectivity, real-time monitoring, and app integration, which improve patient compliance and give useful data to healthcare providers.

Increasing Prevalence of Chronic Diseases:

The growing prevalence of chronic diseases such as diabetes, cancer, and autoimmune disorders is fueling demand for wearable injectors. These devices provide a practical and effective approach to managing long-term prescription regimens, enhancing patient quality of life by allowing for at-home care.

Patient-Centered Healthcare Solutions:

The rising emphasis on patient-centered healthcare is driving the introduction of wearable injectors. These devices are designed to be user-friendly, reducing discomfort and allowing for self-administration. This move advances the trend of individualized medicine by empowering people to manage their own care.

Regulatory Approvals and Market Expansion:

The market is developing as more wearable injectors obtain regulatory authorization around the world. This not only expands their availability but also raises customer trust in their safety and efficacy. Furthermore, organizations are increasing their market presence through strategic alliances and collaborations, which improve product reach and adoption.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Wearable Injector Devices Market Regional Analysis

Here is a more detailed regional analysis of the global Wearable Injector Devices Market:

North America:

North America has a well-developed healthcare infrastructure that facilitates the introduction of innovative medical technologies, such as wearable injector devices. The existence of world-class hospitals, research institutions, and healthcare facilities enables the rapid integration of these devices into patient care. Furthermore, the region has strong healthcare funding and reimbursement rules that promote innovation and use of cutting-edge medical technologies.

The increased prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disease in North America fuels demand for wearable injector devices. These devices provide a simple and effective way to manage long-term pharmaceutical regimens, which is critical for patients with chronic diseases. The growing number of patients requiring ongoing therapy creates a significant market for these advanced drug delivery systems.

North America's strong regulatory environment protects the safety and efficacy of medical products, boosting consumer confidence. Regulatory bodies such as the FDA establish clear guidelines and pathways for the approval and commercialization of wearable injectors. This regulatory support not only speeds up the introduction of innovative technologies to the market, but it also reassures healthcare providers and patients about their dependability.

The region is a hotbed of technical innovation and healthcare-related research and development. Companies and research organizations in North America are investing extensively in next-generation wearable injectors with advanced features including connectivity and real-time monitoring. This ongoing focus on innovation improves product offerings and establishes North America as a market leader in wearable injector devices.

Asia Pacific:

Asia Pacific is experiencing significant expansion in healthcare infrastructure, which is fueling the growth of the Wearable Injector Devices Market. Governments throughout the area are raising healthcare budgets and investing in cutting-edge medical technologies to improve patient care. This investment promotes the use of novel equipment such as wearable injectors in hospitals and clinics. Improved healthcare facilities attract a larger patient population, which fuels market expansion.

Diabetes, cancer, and cardiovascular disease are all on the rise in the region. This surge in chronic illnesses needs long-term and efficient treatment alternatives, making wearable injectors an intriguing solution. These technologies enable patients to manage their diseases at home, minimizing the need for frequent hospital visits. The expanding patient population, with chronic diseases boosts the demand for wearable injectors.

Economic expansion in countries such as China, India, and Japan is resulting in increasing disposable incomes and healthcare spending among the population. People with larger financial means are more inclined to invest in innovative healthcare solutions, such as wearable injector devices. Furthermore, increased healthcare knowledge and education are encouraging people to seek out better and more convenient treatment options, hence promoting market growth.

The regulatory climate in Asia Pacific is becoming more conducive to medical device innovation and commercialization. Governments are creating favorable regulations and expediting the approval process for new medical technologies. This creates a favorable environment for the introduction and use of wearable injector devices. The ease with which regulatory licenses are granted increases market entry and expansion for regional producers and distributors of such devices.

Global Wearable Injector Devices Market: Segmentation Analysis

The Global Wearable Injector Devices Market is Segmented on the basis of Type, Therapy, End-User, And Geography.

Wearable Injector Devices Market, By Type

• On-Body Injectors
• Off-Body Injectors

Based on Type, the market is segmented into On-Body Injectors and Off-Body Injectors. On-body wearable injectors accounted for the greatest revenue share in 2023, owing to rising demand because these patches are pleasant to wear on the skin (stomach), are water resistant, and are convenient to use at home. On-body wearable injectors have several advantages, including fewer hospital visits, lower healthcare costs, lifecycle management, customizable dosing, and automatic warming of cold medications. Off-body wear removes hazards such as painful device removal, adhesive fitting difficulties, and skin sensitivity or irritation.

Wearable Injector Devices Market, By Therapy

• Immuno-Oncology
• Diabetes
• Cardiovascular Diseases

Based on Therapy, The market is segmented into Immuno-Oncology, Diabetes, and Cardiovascular Diseases. During the projection period, the diabetes category has the most share. This category's significant position may be attributable to the rising prevalence of diabetes worldwide, as well as the increasing availability of wearable injectors for the treatment of chronic diseases, which is moving this market segment forward.

Wearable Injector Devices Market, By End-User

• Hospitals
• Home Care Settings
• Clinics

Based on End-User, The market is segmented into Hospitals, Home Care Settings, and Clinics. The hospital and clinic segment has a larger market share. The growing preference for self-administration of medication, as well as the growing need to cut healthcare costs, can be attributed to this segment's significant share. Furthermore, the growing need for technologically advanced drug administration systems that lower hospitalization rates while requiring minimal expertise is expected to drive the home healthcare settings market ahead.

Wearable Injector Devices Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, The Global Wearable Injector Devices Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The Wearable Injector Devices Market in North America is the world's largest. The high prevalence of chronic and lifestyle-related illnesses, as well as the availability of advanced healthcare infrastructure in the region, account for North America's large share of this market.

Key Players

• The "Global Wearable Injector Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Valeritas, SteadyMed Therapeutics, Tandem Diabetes Care, Amgen, Medtronic, Insulet Corporation, United Therapeutic Corporation, Enable Injections, Ypsomed and Becton, Dickinson and Company.
• The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

• Wearable Injector Devices Market Recent Developments
• In February 2023, Insulet Corporation purchased the assets of Automated Glucose Control LLC (AGC), a firm dedicated to developing and marketing best-in-class automated insulin delivery technology. The company participated in the creation of Omnipod (Insulet's flagship product).
• In January 2023, Tandem purchased Capillary Biomedical, an infusion set developer.
• In July 2022, Becton Dickinson and Company purchased Parata Systems. This acquisition will assist BD's market growth.
• In January 2022, enable injections were obtained. The company obtained USD 215 million in Series C investment. The cash will be used to onboard Enable Injections and major new pharma partner initiatives, as well as to speed the commercialization of their products and platforms with existing pharma partners.
• In September 2021, Ypsomed AG introduced the YpsoDose single-use injector, which is an electromechanical pre-filled and pre-assembled patch device for 10 mL glass cartridges. Automatically completed steps include needle insertion, injection, end-of-injection feedback, and needle safety. The needle is kept hidden at all times and is rendered safe following injection and device removal.

TABLE OF CONTENTS

1. Introduction of Global Wearable Injector Devices Market

• Introduction of the Market
• Scope of Report
• Assumptions

2. Executive Summary

3. Research Methodology of Verified Market Research

• Data Mining
• Validation
• Primary Interviews
• List of Data Sources

4. Global Wearable Injector Devices Market Outlook

• Overview
• Market Dynamics
• Drivers
• Restraints
• Opportunities
• Porters Five Force Model
• Value Chain Analysis

5. Global Wearable Injector Devices Market, By Type

• Overview
• On-Body Injectors
• Off-Body Injectors

6. Global Wearable Injector Devices Market, By Therapy

• Overview
• Immuno-Oncology
• Diabetes
• Cardiovascular Diseases

7. Global Wearable Injector Devices Market, By End-User

• Overview
• Hospitals
• Home Care Settings
• Clinics

8. Global Wearable Injector Devices Market, By Geography

• Overview
• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• Rest of the World
• Latin America
• Middle East & Africa

9. Global Wearable Injector Devices Market Competitive Landscape

• Overview
• Company Market Ranking
• Key Development Strategies

10. Company Profiles

• Valeritas
• SteadyMed Therapeutics
• Tandem Diabetes Care
• Amgen
• Medtronic
• Insulet Corporation
• United Therapeutic Corporation
• Enable Injections
• Ypsomed and Becton
• Dickinson and Company

11. Appendix

• Related Research